Histone Deacetylase Inhibitors as Cancer Therapeutics by Steven Grant

Histone Deacetylase Inhibitors as Cancer Therapeutics

bySteven Grant, Steven Grant

Other | December 31, 2012

not yet rated|write a review

Pricing and Purchase Info

$147.19 online 
$184.00
Earn 736 plum® points

In stock online

Ships free on orders over $25

Not available in stores

about

Advances in Cancer Research provides invaluable information on the exciting and fast-moving field of cancer research. This thematic volume looks at "Histone Deacetylase Inhibitors as Cancer Therapeutics."

  • Provides invaluable information on the exciting and fast-moving field of cancer research
  • This thematic volume looks at "Histone Deacetylase Inhibitors as Cancer Therapeutics"
  • Outstanding and original reviews

Details & Specs

Title:Histone Deacetylase Inhibitors as Cancer TherapeuticsFormat:OtherDimensions:288 pages, 1 × 1 × 1 inPublished:December 31, 2012Publisher:Elsevier ScienceLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0123946085

ISBN - 13:9780123946089

Customer Reviews of Histone Deacetylase Inhibitors as Cancer Therapeutics

Reviews

Extra Content

Table of Contents

      1. Histone Deacetylase Inhibitors Disrupt the Mitotic Spindle Assembly Checkpoint by Targeting Histone and Non-Histone Proteins
      2. Mechanisms of Resistance to Histone Deacetylase Inhibitors
      3. HDAC Inhibitors: Roles of DNA Damage and Repair
      4. HDAC Inhibitor Modulation of Proteotoxicity as a Therapeutic Approach in Cancer
      5. Intrinsic and Extrinsic Apoptotic Pathway Signaling as Determinants of Histone Deacetylase Inhibitor Anti-Tumor Activity
      6. Histone Deacetylase Inhibitors and Rational Combination Therapies
      7. HDAC Inhibitors and Chaperone Function